B5L-76046-14001
6 vaccinations
10 coded responses
56 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 857 / AZ
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Registered in v-safe
-
2021-01-29
Survey response — days 1–6 daily, dose 1MedDRA: Mast cell activation syndrome — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: I have Mast Cell Activation DisorderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Mast cell activation syndrome — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Mast Cell activation disorderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Mast cell activation syndrome — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: I have Mast Cell Activation SyndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Mast cell activation syndrome — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: I have Mast Cell Activation DisorderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-04
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-11
- 2021-02-18
-
2021-02-19
Dose 2 — Pfizer-BioNTech
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Site: Redness, Itching · Diarrhea, Rash, not including the immediate area around the injection siteFree text: Mast Cell Activation DisorderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 7, dose 2MedDRA: Mass, Mast cell activation syndrome — Feeling: Fair · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Mast cell activation disorderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-27
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2021-08-22
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-03
- 2021-11-21
- 2022-02-20
-
2022-02-21
Dose 4 — Pfizer-BioNTech
-
2022-02-21
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Redness, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-02-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-24
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction, Pre-existing disease, Self-medication — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Systemic mast cell reactions (rejecting formerly healed piercings) but I did start to wean off my prophylactic Benadryl todayMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Survey response — days 1–6 daily, dose 4MedDRA: Condition aggravated, Pre-existing disease, Self-medication — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: systemic mast cell symptoms (rejection of previously healed piercings, old wounds reopening); trying to wean off Benadryl; I have mast cell activation disorderMedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Survey response — days 1–6 daily, dose 4MedDRA: Condition aggravated, Pre-existing disease, Self-medication — Feeling: Fair · Headache, Fatigue or tirednessFree text: Continuing mast cell systemic symptoms- rejecting previously healed piercings, old wounds reopening; I have mast cell activation disorder and have been weaning off my prophylactic Benadryl the last few daysMedDRA releases: 2024-11 · check-in free text available
-
2022-02-27
Survey response — days 1–6 daily, dose 4MedDRA: Mast cell activation syndrome, Self-medication — Feeling: Fair · Fatigue or tirednessFree text: systemic mast cell activation symptoms- rejecting previously healed piercings (I have mast cell activation disorder and have been trying to wean off my prophylactic Benadryl)MedDRA releases: 2024-11 · check-in free text available
- 2022-02-28
- 2022-03-07
- 2022-03-14
- 2022-03-21
- 2022-03-28
- 2022-04-05
- 2022-05-23
- 2022-08-23
-
2022-09-08
Dose 5 — Pfizer-BioNTech
- 2022-09-14
- 2022-09-17
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-08
-
2023-03-06
Dose 6 — Pfizer-BioNTech
- 2023-03-09
-
2023-03-09
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2023-03-10
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2023-03-11
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2023-03-12
Health check-in — days 1–6 daily, dose 6Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2023-03-13
- 2023-03-20
- 2023-03-27
- 2023-04-03
- 2023-04-10
- 2023-04-17
- 2023-06-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-08-22 | Pfizer-BioNTech | No |
| 4 | 2022-02-21 | Pfizer-BioNTech | No |
| 5 | 2022-09-08 | Pfizer-BioNTech | No |
| 6 | 2023-03-06 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): I have Mast Cell Activation Disorder
Systemic reaction (other): Mast Cell activation disorder
Systemic reaction (other): I have Mast Cell Activation Syndrome
Systemic reaction (other): I have Mast Cell Activation Disorder
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Mast Cell Activation Disorder
Release 4 — day 7, dose 2
Systemic reaction (other): Mast cell activation disorder
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Systemic mast cell reactions (rejecting formerly healed piercings) but I did start to wean off my prophylactic Benadryl today
Systemic reaction (other): systemic mast cell symptoms (rejection of previously healed piercings, old wounds reopening); trying to wean off Benadryl; I have mast cell activation disorder
Systemic reaction (other): Continuing mast cell systemic symptoms- rejecting previously healed piercings, old wounds reopening; I have mast cell activation disorder and have been weaning off my prophylactic Benadryl the last few days
Systemic reaction (other): systemic mast cell activation symptoms- rejecting previously healed piercings (I have mast cell activation disorder and have been trying to wean off my prophylactic Benadryl)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Mass | ✓ | ✓ | ○ |
| SRO | Mast cell activation syndrome | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release